Page 96 - MemoriaCIBER2019-ENG

96
CIBER Annual report 2019
Linked Clinical Groups
Group Leader
P Encarna Guillén P Feliciano J. Ramos
P Jordi Rosell
P Isabel Tejada (1)
P Luis Aldámiz- Echevarría Azuara
P Ma Luz Couce P Luis González
Gutiérrez-Solana P Eduardo López Laso P Guillem Pintos
P Mireia del Toro
P Irene Halperin
P Antonio Picó
P Manuel Puig Domingo P Alfonso Soto
P Isabel Badell P Cristina Beléndez P Albert Català P Julián Sevilla P Joan-Lluis Vives-
Corrons (1)
(1) Group decommissioned in 2020
Institution / Centre
Province
Paediatric and Developmental Medicine Research Programme
Hospital Virgen de la Arrixaca
Murcia
Hospital Lozano Blesa
Zaragoza
Hospital Son Espases
Illes Balears
Hospital Cruces
Bilbao
Inherited Metabolic Medicine Research Programme
Hospital Cruces
Bilbao
Hospital Clínico de Santiago de Compostela
A Coruña
Hospital Infantil Niño Jesús
Madrid
Hospital Reina Sofía
Córdoba
Hospital Germans Trías i Pujol
Barcelona
Hospital Vall d‘Hebrón
Barcelona
Endocrine Medicine Research Programme
Hospital Clínic
Barcelona
Hospital General de Alicante
Alicante
Hospital Germans Trías i Pujol,
Barcelona
Hospital Virgen del Rocío
Sevilla
Inherited Cancer, Haematologic and Dermatological Diseases Research Programme
Hospital de la Santa Creu i Sant Pau
Barcelona
Hospital Gregorio Marañón
Madrid
Hospital San Joan de Déu
Barcelona
Hospital Infantil Niño Jesús
Madrid
Hospital Clínic
Barcelona
Patents owned by CIBER
Patents granted
• Granted in several countries. Peptides derived from GSE24.2 to treat diseases caused by oxidative stress and DNA damage.
Patents applied for
• Compounds for treating Mcardle disease.
• Method of increasing mitochondrial DNA copy number.
• Ergothioneine, s-methyl-ergothioneine, and uses thereof.
• Addressing the diagnostic gaps in pyruvate kinase deficiency: Consensus recommendations on the diagnosis of pyruvate kinase deficiency.